Seb Jantet, Mirada’s Chief Financial and Operations Officer has over 25 years of experience in finance, both in the public and private markets. Most recently he was Chief Financial Officer of Induction Healthcare PLC, during which time he steered the company through an AIM IPO, raising just under £17m from investors. Prior to that he was Chief Financial officer of DrugDev Inc, which he joined in 2013 and was part of the team that executed a buy and build strategy in the clinical trials technology market, ultimately culminating in a successful exit to IQVIA in 2017.
Seb also spent 22 years working in the city, 11 years of which working at Investec as a top-ranked healthcare analyst and heading up the healthcare equity research team. Prior to that, he worked 4 years for KPMG working in corporate finance. Seb is a qualified accountant, a member of the Institute of Chartered Accountants of England and Wales and has a BA in French and Politics from the University of East Anglia. He is also a non-executive director of Elizabeth Finn Homes Limited